Mechanisms of inhibition of insulin release

American Journal of Physiology

Volumn 271, Issue 6 PART 1, 1996, Pages

  Sharp, Geoffrey W G ^a  

^a Animal Health Diagnostic Center   (United States)

Author keywords

G proteins; exocytosis; Galanin; Insulin release; Norepinephrine; Pancreatic cell; Somatostatin; Stimulus secretion coupling

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ARACHIDONIC ACID; CALCIUM CHANNEL; CARBACHOL; FLUORIDE SODIUM; GALANIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MASTOPARAN; NORADRENALIN; PERTUSSIS TOXIN; POTASSIUM CHANNEL; PROSTAGLANDIN; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

CALCIUM TRANSPORT; CELL LINE; DEPOLARIZATION; ENZYME INHIBITION; EXOCYTOSIS; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; STIMULUS SECRETION COUPLING;

ANIMALS; EXOCYTOSIS; GTP-BINDING PROTEINS; HUMANS; INSULIN; ISLETS OF LANGERHANS;

EID: 0030474003     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.271.6.c1781     Document Type: Article

References (134)

1. + channel in the β-cell? Peptides 10: 453-457, 1989.
2. Amiranoff, B., A.-M. Lorinet, I. Lagny-Pourmir, and M. Laburthe. Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. Eur. J. Biochem. 177: 147-152, 1989.
3. Ämmälä, C., F. M. Ashcroft, and P. Rorsman. Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature Lond. 363: 356-358, 1993.
4. Ashcroft, F., D. E. Harrison, and S. J. H. Ashcroft. Glucose induces closure of single potassium channels in isolated rat pancreatic islets. Nature Lond. 312: 446-448, 1984.
5. Band, A. M., P. M. Jones, and S. L. Howell. The mechanism of arachidonic acid-induced insulin secretion from rat islets of Langerhans. Biochim. Biophys. Acta 1176: 64-68, 1993.
6. Berridge, M. J., and R. F. Irvine. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature Lond. 312: 315-321, 1984.
7. Berrow, N. S., G. Milligan, and N. G. Morgan. Immunological characterization of the guanine-nucleotide binding proteins Gi and Go in rat islets of Langerhans. J. Mol. Endocrinol. 8: 103-108, 1992.
8. Blachier, F., and W. J. Malaisse. Possible role of a GTP-binding protein in the activation of phospholipase C by carbarnylcholine in tumoral insulin-producing cells. Res. Commun. Chem. Pathol. Pharmacol. 58: 237-255, 1987.
9. Bokvist, K., C. Ammala, P. O. Berggren, P. Rorsman, and L. Wahlander. Alpha 2-adrenergic stimulation does not inhibit L-type calcium channels in mouse pancreatic β-cells. Biosci. Rep. 11: 147-157, 1991.
10. Boyd, R. S., M. J. Duggan, C. C. Shone, and K. A. Foster. The effect of botulinum neurotoxins on the release of insulin from the insulinoma cell lines HIT-15 and RINm5F. J. Biol. Chem. 270: 18216-18218, 1995.
11. Cable, H. C., A. el-Mansoury, and N. G. Morgan. Activation of alpha-2-adrenoceptors results in an increase in F-actin formation in HIT-T15 pancreatic B-cells. Biochem. J. 307: 169-174, 1995.
12. 2+ and calmodulin on adenylyl cyclase activity in plasma membranes derived from neuronal and non-neuronal cells. Cell Calcium 13: 107-121, 1992.
13. Carter, B. D., and F. Medzihradsky. Go mediates the coupling of the μ opiod receptor to adenylyl cyclase in cloned neural cell and brain. Proc. Natl. Acad. Sci. USA 90: 4062-4066, 1993.
14. Chen, S., A. Ogawa, M. Ohneda, R. H. Unger, D. W. Foster, and J. D. McGarry. More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic-cell signalling. Diabetes 43: 878-883, 1994.
15. + channels in pancreatic B-cells. Nature Lond. 311: 271-273, 1984.
16. Cook, D. L., and E. Perara. Islet electrical pacemaker response to alpha-adrenergic stimulation. Diabetes 31: 985-990, 1982.
17. Corkey, B. E., M. C. Glennon, K. S. Chen, J. T. Deeney, F. M. Matschinsky, and M. Prentki. A role for malonyl-coA in glucose-stimulated insulin secretion from clonal pancreatic b-cells. J. Biol. Chem. 264: 21608-21612, 1989.
18. Cormont, M., Y. Le Marchand-Brustel, E. Van Obberghen, A. M. Spiegel, and G. W. G. Sharp. Identification of G protein α-subunits in RINm5F cells and their selective interaction with galanin receptor. Diabetes 40: 1170-1176, 1991.
19. 3 Biochem. J. 303: 369-375, 1994.
20. + channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc. Natl. Acad. Sci. USA 85: 1312-1316, 1988.
21. + channels in insulinoma cells: activation by somatostatin and protein kinase C. Proc. Natl. Acad. Sci. USA 88: 2971-2975, 1989.
22. Drews, G., A. Debuyser, and J.-C. Henquin. Significance of the membrane repolarization and cyclic AMP changes in mouse pancreatic B-cells for the inhibition of insulin release by galanin. Mol. Cell. Endocrinol. 105: 97-102, 1994.
23. + permeability of the B-cell membrane. Endocrinology 126: 1646-1653, 1990.
24. 86Rb efflux and membrane potential in mouse B-cells suggests sharing of common targets. Biochim. Biophys. Acta 1175: 214-218, 1993.
25. Drucker, D. J., J. Philippe, S. Mojsov, W. L. Chick, and J. F. Habener. Glucagon-like peptide-1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA 84: 3434-3438, 1987.
26. + channels in insulin-secreting cells via a pertussis toxin-sensitive G-protein. EMBO J. 8: 413-420, 1989.
27. + channels in an insulin secreting cell line are inhibited by D-glyceraldehyde and activated by membrane permeabilization. J. Membr. Biol. 93: 271-273, 1986.
28. Easom, R. A., M. Land, J. R. Colca, J. H. Hughes, J. Turk, and M. McDaniel. Effects of insulin secretagogues on protein kinase C-catalyzed phosphorylation of an endogenous substrate in isolated pancreatic islets. J. Biol. Chem. 265: 14938-14946, 1990.
29. Eddlestone, G. T., M. Komatsu, L. Shen, and G. W. G. Sharp. Mastoparan increases the intracellular free calcium concentration in two insulin-secreting cell lines by inhibition of ATP-sensitive potassium channels. Mol. Pharmacol. 47: 787-797, 1995.
30. Fehmann, H. C., M. Janssen, and B. Goke. Interaction of glucagon-like peptide-1 and galanin in insulin (βTC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells. Acta Diabetol. 32: 176-181, 1995.
31. Ferro-Novick, S., and R. Jahn. Vesicle fusion from yeast to man. Nature Lond. 370: 191-193, 1994.
32. + channels in insulinoma cells. FEBS Lett. 242: 94-96, 1988.
33. Fridolf, T., and B. Ahren. Dual action of the neuropeptide galanin on the cytoplasmic free calcium concentration in RINm5F cells. Biochem. Biophys. Res. Commun. 191: 1224-1229, 1993.
34. + channels in mouse B cells. J. Clin. Invest. 89: 1288-1295, 1992.
35. Gerhardt, M. A., and R. R. Neubig. Multiple Gi protein subtypes regulate a single effector mechanism. Mol. Pharmacol. 40: 707-711, 1991.
36. Gilbey, S. G., J. Stephenson, D. J. O'Halloran, J. M. Burrin, and S. R. Bloom. High dose porcine galanin infusion and effect on intravenous glucose tolerance in humans. Diabetes 38: 1114-1116, 1989.
37. Gillison, S. L., and G. W. G. Sharp. ADP ribosylation by cholera toxin identifies three G-proteins that are activated by the galanin receptor. Studies with RINm5F cell membranes. Diabetes 43: 24-32, 1994.
38. 2+-ATPase activity of rat islet cells and insulin secretion. J. Endocrinol. 134: 221-225, 1992.
39. Gulbenkian, A., L. Schobert, C. Nixon, and A. Tabachnick. Metabolic effects of pertussis sensitization in mice and rats. Endocrinology 83: 885-892, 1968.
40. + permeabililty and membrane potential in insulin-secreting cells. In: Nutrient Regulation of Insulin Secretion, edited by P. R. Flatt. London: Portland, 1992, chapt. 9, p. 173-191.
41. + on arginine stimulation of insulin release in isolated mouse islets. Diabetalogia 30: 659-665, 1987.
42. Hermouet, S., J. J. Merendino, J. S. Gutkind, and A. M. Spiegel. Activating and inactivating mutations of the α-subunit of Gi2 may have opposite effects on proliferation of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 88: 10455-10459, 1991.
43. Hillaire-Buys, D., R. Gross, M. Roye, G. Ribes, and M.-M. Loubatières-Mariani. Adrenergic inhibition of insulin secretion involves pertussis toxin-sensitive and insensitive mechanisms. Eur. J. Pharmacol. 218: 359-362, 1992.
44. 2+ current in the RINm5f cell line. Proc. Natl. Acad. Sci. USA 88: 8744-8748, 1991.
45. Howell, S. L., and W. Montague. Adenylate cyclase activity in isolated rat islets of Langerhans: effects of agents which alter rates of insulin secretion. Biochim. Biophys. Acta 320: 44-52, 1973.
46. 2+ channels in the beta cell. J. Biol. Chem. 266: 837-843, 1991.
47. Hurst, R. D., and N. G. Morgan. Evidence for differential effects of noradrenaline and somatostatin on intracellular messenger systems in rat islets of Langerhans J. Mol. Endocrinol. 4: 231-237, 1990.
48. Jacobsonn, B., A. Bean, R. Scheller, L. Juntti-Bergren, J. Deany, P.-O. Berggren, and B. Meister. Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cells. Proc. Natl. Acad. Sci. USA 91: 12487-12491, 1994.
49. 2+-induced insulin secretion from electrically permeabilised islets of Langerhans. FEBS Lett. 219: 139-44, 1987.
50. Jones, P. M., F. M. Mann, S. J. Persaud, and C. P. D. Wheeler-Jones. Mastoparan stimulates insulin secretion from pancreatic β-cells by effects at a late stage in the secretory pathway. Mol. Cell. Endocrinol. 94: 97-103, 1993.
51. 2+, cyclic AMP, a phorbol ester and noradrenaline. Biochem. J. 254: 397-403: 1988.
52. Kalkbrenner, F., V. E. Degtiar, M. Schenker, S. Brendel, A. Zobel, J. Hescheler, B. Wittig, and G. Schultz. Subunit composition of G(o) proteins functionally coupling galanin receptors to voltage-gated calcium channels. EMBO J. 14: 4728-4737, 1995.
53. Katada, U., and M. Ui. The effect of in vivo pretreatment of rats with a new protein purified from Bordetella pertussis on in vitro secretion of insulin: role of calcium. Endocrinology 1204: 1822-1827, 1979.
54. Keahey, H. H., A. E. Boyd III, and D. L. Kunze. Catecholamine modulation of calcium currents in clonal pancreatic β-cells. Am. J. Physiol. 257 (Cell Physiol. 26): C1171-C1176, 1989.
55. Komatsu, M., T. Aizawa, N. Yokokawa, Y. Sato, N. Takasu, and T. Yamada. Mastoparan-induced hormone release from rat pancreatic islets. Endocrinology 130: 221-228, 1992.
56. Komatsu, M., A. M. McDermott, S. L. Gillison, and G. W. G. Sharp. Time course of action of pertussis toxin to block the inhibition of stimulated insulin release by norepinephrine. Endocrinology 136: 1857-1863, 1995.
57. 2+-independent late site in stimulus-secretion coupling. Studies with the RINm5F β-cell line. J. Biol. Chem. 268: 23297-23306, 1993.
58. Komatsu, M., A. M. McDermott, and G. W. G. Sharp. Sodium fluoride evokes exocytosis by a novel mechanism, possibly at a late site of calcium interaction in stimulus-secretion coupling. Mol. Pharmacol. 47: 496-508, 1995.
59. 2+ in rat pancreatic islets Proc. Natl. Acad. Sci. USA 92: 728-732, 1995.
60. 2 and insulin secretion in pancreatic islets. Biochim. Biophys. Acta 1135: 215-220, 1992.
61. Konrad, R. J., R. A. Young, R. D. Record, R. M. Smith, P. Butkerait, D. Manning, L. Jarett, and B. A. Wolf. The heterotrimeric G-protein Gi is localized to the insulin secretory granules of β-cells and is involved in insulin exocytosis. J. Biol. Chem. 270: 12869-12876, 1995.
62. Kowluru, A., and S. A. Metz. Stimulation by prostaglandin E2 of a high affinity GTPase in the secretory granules of normal rat and human pancreatic islets. Biochem. J. 15: 399-406, 1994.
63. Kowluru, A., M. E. Rabiglia, K. E. Muse, and S. A. Metz. Subcellular localization and kinetic characterization of guanine nucleotide binding proteins in normal rat and human pancreatic islets and tranformed cells. Biochim. Biophys. Acta 1222: 348-359, 1994.
64. Lang, J., I. Nishimoto, R. Regazzi, C. Kiraly, U. Weller, and C. B. Wollheim. Direct control of exocytosis by receptor-mediated activation of the heterotrimeric GTPases Gi and Go or by the expression of their active α-subunits. EMBO J. 14: 3635-3644, 1995.
65. Lankat-Buttergereit, B., H. C. Fehman, B. J. Hering, R. G. Bretzel, and B. Goke. Expression of the ras-related rab3a gene in human isulinomas and normal human pancreatic islets. Pancreas 9: 434-438, 1994.
66. Laychock, S. G. Alpha 2-adrenoceptor stimulation affects total glucose utilization in isolated islets of Langerhans. Mol. Pharmacol. 32: 241-248, 1987.
67. 2 adrenoceptor agonists inhibit the pentose shunt in pancreatic islets. Arch. Biochem. Biophys. 269: 354-358, 1989.
68. Laychock, S. G., and S. Bilgin. Alpha 2-adrenergic inhibition of pancreatic islet glucose utilization is mediated by an inhibitory guanine nucleotide regulatory protein. FEBS Lett. 218: 7-10, 1987.
69. 2-adrenoceptor modulation of glucose utilization and insulin secretion in pancreatic islets. Biochem. Pharmacol. 38: 2511-2520, 1989.
70. Li, G., R. Regazzzi, W. E. Balch, and C. B. Wollheim. Stimulation of insulin release from permeabilized cells by a synthetic peptide corresponding to the effector domain of the small GTP-binding protein rab3. FEBS Lett. 327: 145-149, 1993.
71. Lindskog, S., and B. Ahren. Studies on the mechanism by which galanin inhibits insulin secretion in islets. Eur. J. Pharmacol. 205: 21-27, 1991.
72. Mathias, P. C., L. Best, and W. J. Malaisse. Stimulation by glucose and carbamylcholine of phospholipase C in pancreatic islets. Cell Biochem. Funct. 3: 173-177, 1985.
73. 3. Biochem. J. 284: 565-568, 1992.
74. McDermott, A., and G. W. G. Sharp. Inhibition of insulin secretion; a fail-safe system. Cell. Signalling 5: 229-234, 1993.
75. McDermott, A. M., and G. W. G. Sharp. Gi-2 and Gi-3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell. Diabetes 44: 453-459, 1995.
76. McKenzie, F. R., and G. Milligan. δ-Opiod-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2. Biochem. J. 267: 391-398, 1990.
77. 2+ mobilization and protein kinase C. Diabetes 37: 1453-1469, 1988.
78. Misler, S., L. C. Falke, K. Gillis, and M. L. McDaniel. A metabolite-regulated potassium channel in rat pancreatic beta cells. Proc. Natl. Acad. Sci. USA 83: 7119-7123, 1986.
79. Mizuta, M., N. Inagaki, Y. Nemoto, S. Matsukuru, M. Takahasi, and S. Seino. Synaptotagmin III is a novel isoform of rat synaptotagmin expressed in endocrine and neuronal cells. J. Biol. Chem. 169: 11675-11678, 1994.
80. Mojsov, S., G. C. Weir, and J. F. Habener. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas J. Clin. Invest. 79: 616-619, 1987.
81. Morgan, N. G., and W. Montague. Studies on the mechanism of inhibition of glucose-stimulated insulin secretion in rat islets of Langerhans. Biochem. J. 226: 571-576, 1985.
82. Nieuwenhuizen, A. G., S. Karlsson, T. Fridolf, and B. Ahren. Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets. Diabetologia 37: 871-878, 1994.
83. 2+ concentration. J. Biol. Chem. 264: 973-980, 1989.
84. Oiszewski, S., J. T. Deeny, G. T. Schupin, K. P. Williams, B. E. Corkey, and C. J. Rhodes. Rab3A effector domain peptides induce insulin exocytosis via a specific interaction with a cytosolic protein doublet. J. Biol Chem. 269: 27987-27991, 1994.
85. Pace, C. S., M. Murphy, S. Conant, and P. E. Lacey. Somatostatin inhibition of glucose-induced electrical activity in cultured rat islets. Am. J. Physiol. 233 (Cell Physiol. 2): C164-C171, 1977.
86. Persaud, S. J., P. M. Jones, and S. L. Howell. Effects of Bordetella pertussis toxin on catecholamine inhibition of insulin release from intact and electrically permeabilized rat islets. Biochem. J. 258: 669-675, 1989.
87. Petit, P., M. Manteghetti, and M. M. Loubatières-Mariani. Differential effects of purinergic and cholinergic activation on the hydrolysis of membrane polyphosphoinositides in rat pancreatic islets. Biochem. Pharmacol. 37: 1213-1217, 1988.
88. Powis, G., R. Bonjouklian, M. M. Berggren, A. Gallegos, R. Abraham, C. Ashendal, L. Zalkow, W. F. Matter, J. Dodge, G. Grindey, and C. J. Vlahos. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54: 2419-2423, 1994.
89. 2+, cAMP and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol. Rev. 67: 1185-1248, 1987.
90. Prentki, M., S. Vischer, M. C. Glennon, R. Regazzi, J. T. Deeney, and B. E. Corkey. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrientinduced insulin secretion. J. Biol. Chem. 267: 5802-5810, 1992.
91. Rabinovitch, A., E. Cerasi, and G. W. G. Sharp. Adenosine 3′,5′-monophosphate-dependent and inhibitory effects of epinephrine on insulin release in rat pancreatic islets. Endocrinology 102: 1733-1740, 1978.
92. Ramanadham, S., R. W. Gross, X. Han, and J. Turk. Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in β-cell cytosolic calcium ion concentration. Biochemistry 32: 337-346, 1993.
93. 2+- but not for GTP-γ-S-induced insulin secretion. EMBO J. 14: 2723-2730, 1995.
94. 2-adrenergic receptor to the inhibitory G-protein Gi and adenylate cyclase in HT29 cells. Biochem J. 292: 283-288, 1993.
95. + channel in insulin-secreting mammalian HIT and RIN cell lines. J. Physiol. Lond. 485: 73-86, 1995.
96. Richardson, S. B., T. Laya, M. Gibson, N. Eyler, and M. Van Ooy. Somatostatin inhibits vasopressin-stimulated phosphoinositide hydrolysis and influx of extracellular calcium in clonal hamster beta (HIT) cells. Biochem. J. 288: 847-851, 1992.
97. Robertson, R. P., P. Tsai, S. A. Little, H. J. Zhang, and T. F. Walseth. Receptor-mediated adenylate cyclase-coupled mechanism for PGE2 inhibition of insulin secretion in HIT cells. Diabetes 36: 1047-1053, 1987.
98. + channel in mouse pancreatic B cells. Nature Lond. 349: 77-79, 1991.
99. Rothman, J. E. Mechanisms of intracellular protein transport. Nature Lond. 372: 55-63, 1994.
100. Sadoul, K., J. Lang, C. Montecucco, U. Weller, R. Regazzi, S. Catsicas, Wollheim, C. B., and P. A. Halban. SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J. Cell Biol. 128: 1019-1028, 1995.
101. 2+ influx in rat pancreatic β-cell. Diabetes 41: 438-443, 1992.
102. 2+ currents in an insulin-secreting cell line (RINm5F). J. Biol. Chem. 266: 18025-18033, 1991.
103. Seaquist, E. R., M. B. Armstrong, T. W. Gettys, and T. F. Walseth. Somatostatin selectively couples to Goα in HIT-T15 cells. Diabetes 44: 85-89, 1995.
104. Seaquist, E. R., A. R. Neal, K. D. Shoger, T. F. Walseth, and R. P. Robertson. G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes 41: 1390-1399, 1992.
105. Sharp, G. W. G., Y. Le Marchand-Brustel, T. Yada, L. L. Russo, C. R. Bliss, M. Cormont, L. Monge, and E. Van Obberghen. Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. J. Biol. Chem. 264: 7302-7309, 1989.
106. 2+ and calmodulin in rat islets of Langerhans: explanation for the glucose-induced increase in cyclic AMP levels. Diabetes 29: 74-77, 1980.
107. 2-adrenergic inhibition of adenylyl cyclase in platelet membranes; in situ identification with Gα C-terminal antibodies. Proc. Natl. Acad. Sci. USA 86: 7809-7813, 1989.
108. Skoglund, G., C. R. Bliss, and G. W. G. Sharp. Galaninstimulated high-affinity GTPase activity in plasma membranes from RINm5F cells. Diabetes 42: 74-79, 1993.
109. Sollner, T., and J. E. Rothman. Neurotransmission: harnessing fusion machinery at the synapse. Trends Neurosci. 8: 344-347, 1994.
110. Sondek, J., D. G. Lambright, J. P. Noel, H. E. Hamm, and P. B. Sigler. GTPase mechanism of G-proteins from the 1.7-Å crystal structure of transducin alpha-GDP-AIF-4. Nature Lond. 372: 276-279, 1994.
111. Straub, S. G., and G. W. G. Sharp. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by VIP and PACAP. J. Biol. Chem. 271: 1660-1668, 1996.
112. Sudhoff, T. C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature Lond. 375: 645-653, 1995.
113. Szentivanyi, A., C. W. Fishel, and D. W. Talmadge. Adrenal mediation of histamine and serotonin hyperglycemia in normal mice and the absence of adrenal-induced hyperglycemia in pertussis sensitized mice. J. Infect. Dis. 113: 86-91, 1963.
114. Tallent, M., and T. Reisine. Giα1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells. Mol. Pharmacol. 41: 452-455, 1992.
115. 2+. Biomed. Res. 6: 429-432, 1985.
116. 2+ by forskolin and phorbol ester. FEBS Lett. 183: 430-432, 1985.
117. Tang, S., G. C. Yaney, and G. W. G. Sharp. Unusual response to carbachol in the RINm5F cell. Evidence for a distal site of action in stimulus-secretion coupling. Mol. Pharmacol. 47: 863-870, 1995.
118. 2+-induced insulin secretion in permeabilized HIT-T15 cells. Biochem. J. 270: 273-276, 1990.
119. Ullrich, S., and C. B. Wollheim. Galanin inhibits insulin secretion by direct interference with exocytosis. FEBS Lett. 247: 401-404, 1989.
120. Vara, E., and J. Tamarit-Rodriguez. Does cyclic guanosine monophosphate mediate noradrenaline-induced inhibition of islet insulin secretion stimulated by glucose and palmitate? Biochem. J. 278: 243-248, 1991.
121. 2+ uptake, and insulin secretion. Am. J. Physiol. 257 (Endocrinol. Metab. 20): E923-E929, 1989.
122. Wheeler, M. B., L. Sheu, M. Ghai, A. Bouquillon, G. Grondin, U. Weller, A. R. Beaudoin, M. K. Bennett, W. S. Trimble, and H. Y. Gaisano. Characterization of SNARE protein expression in β cell lines and pancreatic islets. Endocrinology 137: 1340-1348, 1996.
123. Wolf, B. A., R. A. Eason, J. H. Hughes, M. L. McDaniel, and J. Urek. Secretagogue-induced diacylglycerol accumulation in isolated pancreatic islets: mass spectrometric characterization of the fatty acyl content indicates multiple mechanisms of generation. Biochemistry 28: 4291-4301, 1989.
124. 2 and D in insulin secretion. In: Insulin Secretion and Pancreatic β-Cell Research, edited by P. R. Flatt and S. Lenzen. London: Smith-Gordon/Nishimura, 1994, chapt. 39, p. 297-304.
125. Wollheim, C. B., and T. J. Biden. Second messenger function of inositol 1,4,5-trisphophate. J. Biol. Chem. 261: 8314-8319, 1986.
126. 2+ fluxes and insulin release in rat pancreatic islets maintained in tissue culture. J. Clin. Invest. 60: 1165-1173, 1977.
127. Wollheim, C. B., and G. W. G. Sharp. Regulation of insulin release by calcium. Physiol. Rev. 61: 914-973, 1981.
128. 2+ concentration. J. Biol. Chem. 264: 2455-2462, 1989.
129. Yada, T., M. Sakurada, K. Ihada, M. Nakata, F. Murata, A. Arimura, and M. Kikuchi. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J. Biol. Chem. 269: 1290-1293, 1994.
130. Yajima, M., K. Hosoda, Y. Kanbayashi, T. Nakamura, K. Nogimori, Y. Nakase, and M. Ui. Islet-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory response of rats. Purification and characterization. J. Biochem. Tokyo 83: 295-303, 1978.
131. Yamatani, Y., T. Chiba, S. Kadowaki, R. Hishikawa, A. Yamaguchi, T. Inui, T. Fujita, and S. Kawazu. Dual action of protein kinase C activation in the regulation of insulin release by muscarinic agonist from rat insulinoma cell line (RINr). Endocrinology 122: 2826-2832, 1988.
132. Zawalich, W. S., and H. Rasmussen. Control of insulin secretion: a model involving calcium and cyclic AMP and diacylglycerol. Mol. Cell. Endocrinol. 70: 119-138, 1990.
133. olfα: complementary deoxyribonucleic acid structure and expression in pancreaic islets and other tissues outside the olfactory neuroepithelium and central nervous system. Endocrinology 133: 2508-2514, 1993.
134. Zigman, J. M., G. T. Westermark, J. LaMendola, and D. F. Steiner. Expression of cone transducin, Gzα, and other G-protein α-subunit messenger ribonucleic acids in pancreatic islets. Endocrinology 135: 31-37, 1994.